Report Detail
Global Nonalcoholic Steatohepatitis (NASH) Market 2024 by Company, Regions, Type and Application, Forecast to 2030
- RnM4601985 |
- 20 July, 2024 |
- Global |
- 111 Pages |
- GIR (Global Info Research) |
- Other
According to our (Global Info Research) latest study, the global Nonalcoholic Steatohepatitis (NASH) market size was valued at USD 3152.9 million in 2023 and is forecast to a readjusted size of USD 41860 million by 2030 with a CAGR of 44.7% during review period.
Non-alcoholic steatohepatitis (NASH), is one of the common liver diseases, often called silent liver disease. The major feature in NASH is fat deposition in the liver, along with inflammation.
Non-alcoholic drinks, also known as mocktails or alcohol-free beverages, are beverages that do not contain any alcohol. These drinks are a popular choice for those who do not consume alcohol, including designated drivers, people who are underage, or individuals who wish to avoid alcohol for personal or health reasons. There are a wide variety of non-alcoholic drinks available, ranging from soft drinks to fresh juices, herbal infusions, and specialty mocktails. Some examples of non-alcoholic drinks include: 1. Soft Drinks: This category includes popular carbonated beverages like cola, lemon-lime sodas, ginger ale, and root beer. These drinks are often sweet and fizzy, providing a refreshing and enjoyable beverage option. 2. Fruit Juices: Freshly squeezed or packaged fruit juices, such as orange, apple, grapefruit, pineapple, or cranberry juice, are a common choice. These juices offer a natural and flavorful alternative to alcoholic beverages. 3. Smoothies: Made from a blend of fruits, vegetables, yogurt, and other ingredients, smoothies provide a nutritious and wholesome non-alcoholic option. They can be customized with various flavors and ingredients to suit individual preferences. 4. Herbal Infusions and Tea: Herbal teas and infusions, such as chamomile, peppermint, green tea, or hibiscus tea, are popular choices. These beverages are caffeine-free and often have relaxing or soothing properties. 5. Mocktails: These are non-alcoholic cocktails that mimic the flavors and presentation of traditional cocktails. They are typically made with a combination of juices, sodas, and garnishes, providing a fancy and enjoyable experience without the alcohol. 6. Sparkling Water: Carbonated water or mineral water with added flavors or fruit infusions is a refreshing and hydrating option. It is often consumed plain or mixed with juices or syrups. These non-alcoholic drinks offer a variety of flavors, textures, and options for those who prefer not to consume alcohol. They are a great way to enjoy a beverage while socializing or relaxing without the effects of alcohol.
The Global Info Research report includes an overview of the development of the Nonalcoholic Steatohepatitis (NASH) industry chain, the market status of Hospital Pharmacy (Obeticholic acid（OCA）, Selonsertib), Online Provider (Obeticholic acid（OCA）, Selonsertib), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Nonalcoholic Steatohepatitis (NASH).
Regionally, the report analyzes the Nonalcoholic Steatohepatitis (NASH) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Nonalcoholic Steatohepatitis (NASH) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Nonalcoholic Steatohepatitis (NASH) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Nonalcoholic Steatohepatitis (NASH) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Obeticholic acid（OCA）, Selonsertib).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Nonalcoholic Steatohepatitis (NASH) market.
Regional Analysis: The report involves examining the Nonalcoholic Steatohepatitis (NASH) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Nonalcoholic Steatohepatitis (NASH) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Nonalcoholic Steatohepatitis (NASH):
Company Analysis: Report covers individual Nonalcoholic Steatohepatitis (NASH) players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Nonalcoholic Steatohepatitis (NASH) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacy, Online Provider).
Technology Analysis: Report covers specific technologies relevant to Nonalcoholic Steatohepatitis (NASH). It assesses the current state, advancements, and potential future developments in Nonalcoholic Steatohepatitis (NASH) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Nonalcoholic Steatohepatitis (NASH) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Nonalcoholic Steatohepatitis (NASH) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Obeticholic acid（OCA）
Selonsertib
Market segment by Application
Hospital Pharmacy
Online Provider
Retail Pharmacy
Market segment by players, this report covers
AstraZeneca
Arena Pharmaceuticals
GSK
Novo Nordisk
Roche
Vivus
Arisaph Pharmaceuticals
Cempra Pharmaceuticals
Galectin Therapeutics
Galmed Pharmaceuticals
Genfit
Gilead
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Nonalcoholic Steatohepatitis (NASH) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nonalcoholic Steatohepatitis (NASH), with revenue, gross margin and global market share of Nonalcoholic Steatohepatitis (NASH) from 2019 to 2024.
Chapter 3, the Nonalcoholic Steatohepatitis (NASH) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Nonalcoholic Steatohepatitis (NASH) market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nonalcoholic Steatohepatitis (NASH).
Chapter 13, to describe Nonalcoholic Steatohepatitis (NASH) research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Nonalcoholic Steatohepatitis (NASH)
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Nonalcoholic Steatohepatitis (NASH) by Type
- 1.3.1 Overview: Global Nonalcoholic Steatohepatitis (NASH) Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Nonalcoholic Steatohepatitis (NASH) Consumption Value Market Share by Type in 2023
- 1.3.3 Obeticholic acid（OCA）
- 1.3.4 Selonsertib
- 1.4 Global Nonalcoholic Steatohepatitis (NASH) Market by Application
- 1.4.1 Overview: Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Hospital Pharmacy
- 1.4.3 Online Provider
- 1.4.4 Retail Pharmacy
- 1.5 Global Nonalcoholic Steatohepatitis (NASH) Market Size & Forecast
- 1.6 Global Nonalcoholic Steatohepatitis (NASH) Market Size and Forecast by Region
- 1.6.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Nonalcoholic Steatohepatitis (NASH) Market Size by Region, (2019-2030)
- 1.6.3 North America Nonalcoholic Steatohepatitis (NASH) Market Size and Prospect (2019-2030)
- 1.6.4 Europe Nonalcoholic Steatohepatitis (NASH) Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size and Prospect (2019-2030)
- 1.6.6 South America Nonalcoholic Steatohepatitis (NASH) Market Size and Prospect (2019-2030)
- 1.6.7 Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 AstraZeneca
- 2.1.1 AstraZeneca Details
- 2.1.2 AstraZeneca Major Business
- 2.1.3 AstraZeneca Nonalcoholic Steatohepatitis (NASH) Product and Solutions
- 2.1.4 AstraZeneca Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 AstraZeneca Recent Developments and Future Plans
- 2.2 Arena Pharmaceuticals
- 2.2.1 Arena Pharmaceuticals Details
- 2.2.2 Arena Pharmaceuticals Major Business
- 2.2.3 Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product and Solutions
- 2.2.4 Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Arena Pharmaceuticals Recent Developments and Future Plans
- 2.3 GSK
- 2.3.1 GSK Details
- 2.3.2 GSK Major Business
- 2.3.3 GSK Nonalcoholic Steatohepatitis (NASH) Product and Solutions
- 2.3.4 GSK Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 GSK Recent Developments and Future Plans
- 2.4 Novo Nordisk
- 2.4.1 Novo Nordisk Details
- 2.4.2 Novo Nordisk Major Business
- 2.4.3 Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Product and Solutions
- 2.4.4 Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Novo Nordisk Recent Developments and Future Plans
- 2.5 Roche
- 2.5.1 Roche Details
- 2.5.2 Roche Major Business
- 2.5.3 Roche Nonalcoholic Steatohepatitis (NASH) Product and Solutions
- 2.5.4 Roche Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Roche Recent Developments and Future Plans
- 2.6 Vivus
- 2.6.1 Vivus Details
- 2.6.2 Vivus Major Business
- 2.6.3 Vivus Nonalcoholic Steatohepatitis (NASH) Product and Solutions
- 2.6.4 Vivus Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 Vivus Recent Developments and Future Plans
- 2.7 Arisaph Pharmaceuticals
- 2.7.1 Arisaph Pharmaceuticals Details
- 2.7.2 Arisaph Pharmaceuticals Major Business
- 2.7.3 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product and Solutions
- 2.7.4 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 Arisaph Pharmaceuticals Recent Developments and Future Plans
- 2.8 Cempra Pharmaceuticals
- 2.8.1 Cempra Pharmaceuticals Details
- 2.8.2 Cempra Pharmaceuticals Major Business
- 2.8.3 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product and Solutions
- 2.8.4 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 Cempra Pharmaceuticals Recent Developments and Future Plans
- 2.9 Galectin Therapeutics
- 2.9.1 Galectin Therapeutics Details
- 2.9.2 Galectin Therapeutics Major Business
- 2.9.3 Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Product and Solutions
- 2.9.4 Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
- 2.9.5 Galectin Therapeutics Recent Developments and Future Plans
- 2.10 Galmed Pharmaceuticals
- 2.10.1 Galmed Pharmaceuticals Details
- 2.10.2 Galmed Pharmaceuticals Major Business
- 2.10.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product and Solutions
- 2.10.4 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
- 2.10.5 Galmed Pharmaceuticals Recent Developments and Future Plans
- 2.11 Genfit
- 2.11.1 Genfit Details
- 2.11.2 Genfit Major Business
- 2.11.3 Genfit Nonalcoholic Steatohepatitis (NASH) Product and Solutions
- 2.11.4 Genfit Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
- 2.11.5 Genfit Recent Developments and Future Plans
- 2.12 Gilead
- 2.12.1 Gilead Details
- 2.12.2 Gilead Major Business
- 2.12.3 Gilead Nonalcoholic Steatohepatitis (NASH) Product and Solutions
- 2.12.4 Gilead Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
- 2.12.5 Gilead Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Nonalcoholic Steatohepatitis (NASH) by Company Revenue
- 3.2.2 Top 3 Nonalcoholic Steatohepatitis (NASH) Players Market Share in 2023
- 3.2.3 Top 6 Nonalcoholic Steatohepatitis (NASH) Players Market Share in 2023
- 3.3 Nonalcoholic Steatohepatitis (NASH) Market: Overall Company Footprint Analysis
- 3.3.1 Nonalcoholic Steatohepatitis (NASH) Market: Region Footprint
- 3.3.2 Nonalcoholic Steatohepatitis (NASH) Market: Company Product Type Footprint
- 3.3.3 Nonalcoholic Steatohepatitis (NASH) Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Nonalcoholic Steatohepatitis (NASH) Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global Nonalcoholic Steatohepatitis (NASH) Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global Nonalcoholic Steatohepatitis (NASH) Consumption Value Market Share by Application (2019-2024)
- 5.2 Global Nonalcoholic Steatohepatitis (NASH) Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America Nonalcoholic Steatohepatitis (NASH) Consumption Value by Type (2019-2030)
- 6.2 North America Nonalcoholic Steatohepatitis (NASH) Consumption Value by Application (2019-2030)
- 6.3 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Country
- 6.3.1 North America Nonalcoholic Steatohepatitis (NASH) Consumption Value by Country (2019-2030)
- 6.3.2 United States Nonalcoholic Steatohepatitis (NASH) Market Size and Forecast (2019-2030)
- 6.3.3 Canada Nonalcoholic Steatohepatitis (NASH) Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Nonalcoholic Steatohepatitis (NASH) Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe Nonalcoholic Steatohepatitis (NASH) Consumption Value by Type (2019-2030)
- 7.2 Europe Nonalcoholic Steatohepatitis (NASH) Consumption Value by Application (2019-2030)
- 7.3 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Country
- 7.3.1 Europe Nonalcoholic Steatohepatitis (NASH) Consumption Value by Country (2019-2030)
- 7.3.2 Germany Nonalcoholic Steatohepatitis (NASH) Market Size and Forecast (2019-2030)
- 7.3.3 France Nonalcoholic Steatohepatitis (NASH) Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Nonalcoholic Steatohepatitis (NASH) Market Size and Forecast (2019-2030)
- 7.3.5 Russia Nonalcoholic Steatohepatitis (NASH) Market Size and Forecast (2019-2030)
- 7.3.6 Italy Nonalcoholic Steatohepatitis (NASH) Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Region
- 8.3.1 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Consumption Value by Region (2019-2030)
- 8.3.2 China Nonalcoholic Steatohepatitis (NASH) Market Size and Forecast (2019-2030)
- 8.3.3 Japan Nonalcoholic Steatohepatitis (NASH) Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Nonalcoholic Steatohepatitis (NASH) Market Size and Forecast (2019-2030)
- 8.3.5 India Nonalcoholic Steatohepatitis (NASH) Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size and Forecast (2019-2030)
- 8.3.7 Australia Nonalcoholic Steatohepatitis (NASH) Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America Nonalcoholic Steatohepatitis (NASH) Consumption Value by Type (2019-2030)
- 9.2 South America Nonalcoholic Steatohepatitis (NASH) Consumption Value by Application (2019-2030)
- 9.3 South America Nonalcoholic Steatohepatitis (NASH) Market Size by Country
- 9.3.1 South America Nonalcoholic Steatohepatitis (NASH) Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Nonalcoholic Steatohepatitis (NASH) Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Nonalcoholic Steatohepatitis (NASH) Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Country
- 10.3.1 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Nonalcoholic Steatohepatitis (NASH) Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Nonalcoholic Steatohepatitis (NASH) Market Size and Forecast (2019-2030)
- 10.3.4 UAE Nonalcoholic Steatohepatitis (NASH) Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 Nonalcoholic Steatohepatitis (NASH) Market Drivers
- 11.2 Nonalcoholic Steatohepatitis (NASH) Market Restraints
- 11.3 Nonalcoholic Steatohepatitis (NASH) Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Nonalcoholic Steatohepatitis (NASH) Industry Chain
- 12.2 Nonalcoholic Steatohepatitis (NASH) Upstream Analysis
- 12.3 Nonalcoholic Steatohepatitis (NASH) Midstream Analysis
- 12.4 Nonalcoholic Steatohepatitis (NASH) Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Nonalcoholic Steatohepatitis (NASH). Industry analysis & Market Report on Nonalcoholic Steatohepatitis (NASH) is a syndicated market report, published as Global Nonalcoholic Steatohepatitis (NASH) Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Nonalcoholic Steatohepatitis (NASH) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
